Survey efficacy of Melissa officinalis on premature ventricular contraction

Determination of the effect of lemon balm on early ventricular heart rate of patients with pulmonary heart disease referred to the clinic of Heshmat Hospital in Rasht

Clinical trials with control group, with parallel groups, blind, randomized

The samples were selected from among patients with cardiac palpation who were referred to the Hashamat Heart Center. In order to hide the randomization process from sealed envelopes, which were numbered sequentially, the use and envelope of each person was only after confirmation Eligible eligibility criteria for him and signature of the consent form by the individual will be opened.

Entry requirements: No use of sedative drugs, no drug addiction, no history of herbal medicines allergy, palpitations, ages 18-60, PVC less than 15% Non-compliance: Pvc in the field of cardiac ischemia, patients with valvular disorder, heart failure, thyroid dysfunction, anemia, ACS and cardiac approval, psychosis patients and serious psychiatric illnesses certified by a psychiatrist, endocrinology, pregnancy , Taking betablocker medications, treating hypnosis, and treating anti-anxiety and sedative drugs within 10 days before the study, lack of hypothyroidism.

The intervention group of 36 patients with a diagnosis of pvc less than 15% based on Holter-rhythm will be included in the study and will be visited monthly by the cardiologist and will be treated in the event of symptoms. These patients will use lemon balm, containing 2 grams (25) of Timen's herbs, for 3 months, twice a day.  The control group also includes 36 patients with less than 15% of the pvc and monthly asymptomatic, but are not being treated for medication and will be excluded if symptoms develop.

premature ventricular contraction

Random sequences will be generated using the Random Generator program.Based on the random block method and considering the six blocks, 12 blocks will be generated for 72 patients.After generating the list, each person will be assigned a dedicated code and will be recognized by the code during the study.None of the collaborators participating in the study will be aware of the randomization list, and to use the encryption process to hide the sealed envelopes that are numbered sequentially, the use and envelope of each individual only after confirming the eligibility criteria Study for him and signature of the consent form by the person will be opened.Registration and random allocation sequences are done by the collaborator of the project methodology and assignment of interventions is done by the collaborator of the plan.

In order to hide the randomization process from sealed envelopes, which are numbered sequentially, the use and envelope of each individual will be opened only after confirming the eligible eligibility criteria for him and signing the consent form by the individual.